Table 1.

Leukemia-associated phenotypes and their distribution at diagnosis

Aberrant phenotypeFrequency (%)*
CD34+CD56+ 
CD34+CD14+ 
CD34+CD11b+ 46 
CD34+CD49b+ 
CD34+CD69+ 10 
CD34+Icam+ 15 
C-kit+CD56+ 
CD33+CD2+ 
CD33+CD4+ 15 
CD33+CD7+ 51 
CD34+CD15+Hla-Dr+ 11 
CD34+CD33+CD7+ 47 
CD34+CD33+CD19+ 
CD34+CD33+CD4+ 
CD33CD14+Hla-Dr+ 17 
CD33CD15+Hla-Dr+ 19 
CD34+CD11b+C-kit+ 47 
CD34+C-kit+CD56+ 
Aberrant phenotypeFrequency (%)*
CD34+CD56+ 
CD34+CD14+ 
CD34+CD11b+ 46 
CD34+CD49b+ 
CD34+CD69+ 10 
CD34+Icam+ 15 
C-kit+CD56+ 
CD33+CD2+ 
CD33+CD4+ 15 
CD33+CD7+ 51 
CD34+CD15+Hla-Dr+ 11 
CD34+CD33+CD7+ 47 
CD34+CD33+CD19+ 
CD34+CD33+CD4+ 
CD33CD14+Hla-Dr+ 17 
CD33CD15+Hla-Dr+ 19 
CD34+CD11b+C-kit+ 47 
CD34+C-kit+CD56+ 
*

 At least 2 aberrant phenotypes were observed for each case.

or Create an Account

Close Modal
Close Modal